USFDA issues EIR for Marksans Pharma’s Goa manufacturing facility

20 Aug 2024 Evaluate

The USFDA has issued an Establishment Inspection Report (EIR) for the manufacturing facility of Marksans Pharma located at Verna Industrial estate, Verna, Goa, India.  The inspection has now been successfully closed by the USFDA. USFDA has determined that the inspection classification of this facility is Voluntary Action Indicated (VAI). The inspection was conducted by the USFDA at the manufacturing facility of the Company from April 09, 2024 to April 17, 2024. 

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.


Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×